GLYCIOME, LLC

Medtech · Private

PreBioGyn, a preservative-free prebiotic intravaginal lubricant device designed to prevent bacterial vaginosis and reduce cervical cancer risk by optimizing vaginal microecology

Grants
$1.5M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
15
2 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Cervical Cancer Prevention Prebiotic Device$399,993
Federal grantDepartment of Health and Human Services · Phase I · Cervical Cancer Prevention Prebiotic Device$54,975
Federal grantDepartment of Health and Human Services · Phase II · Cervical Cancer Prevention Prebiotic Device$1,039,382
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2252ZINN LABS, INC.——
2253NEUROTYPE INC.——
2254ENGINEERING RESOURCES GROUP INC——
2255GLYCIOME, LLC——
2256SUPERFLUID DX, INC.——
2257Cell-Safe Life Sciences LLC——
2258i2C Solutions, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 15
  • Decreasing Acinetobacter Populations In The Microbiomeapplication
  • Topical, Isotonic Compositions For Genital Usegranted
  • Kits For Topical,isotonic Compositionsgranted
  • Dysbiotic Measurementapplication
  • Microbiome Optimizationapplication
  • Microbiome Optimizationapplication
  • Microbiome Optimizationapplication
  • Microbiome Optimizationapplication
  • Topical, Isotonic Compositions For Genital Useapplication
  • Topical, Isotonic Compositions For Genital Useapplication
  • Topical, Isotonic Compositions For Genital Useapplication
  • Decreasing Acinetobacter Populations In The Microbiomeapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.